rivastigmine teva pharma 4,5 mg kapsułki twarde
teva pharmaceuticals polska sp. z o.o. - rivastigmini hydrogenotartras - kapsułki twarde - 4,5 mg
rivastigmine teva pharma 1,5 mg kapsułki twarde
teva pharmaceuticals polska sp. z o.o. - rivastigmini hydrogenotartras - kapsułki twarde - 1,5 mg
rivastigmine teva pharma 3 mg kapsułki twarde
teva pharmaceuticals polska sp. z o.o. - rivastigmini hydrogenotartras - kapsułki twarde - 3 mg
rivastigmine teva pharma 6 mg kapsułki twarde
teva pharmaceuticals polska sp. z o.o. - rivastigmini hydrogenotartras - kapsułki twarde - 6 mg
dospax 40 mg tabletki powlekane
bausch health ireland limited - drotaverini hydrochloridum - tabletki powlekane - 40 mg
dospax forte 80 mg tabletki powlekane
bausch health ireland limited - drotaverini hydrochloridum - tabletki powlekane - 80 mg
atazanavir zentiva 150 mg kapsułki twarde
zentiva, k.s. - atazanaviri sulfas - kapsułki twarde - 150 mg
atazanavir zentiva 200 mg kapsułki twarde
zentiva, k.s. - atazanaviri sulfas - kapsułki twarde - 200 mg
atazanavir zentiva 300 mg kapsułki twarde
zentiva, k.s. - atazanaviri sulfas - kapsułki twarde - 300 mg
zeposia
bristol-myers squibb pharma eeig - ozanimod chlorowodorek - multiple sclerosis, relapsing-remitting; colitis, ulcerative - leki immunosupresyjne - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.